Sign up for the latest intelligence
In 2022, a key challenge for life sciences companies will be to identify the best ways to extract value from RWD to assess brand health for their unique context. Whether your brand is on-market already or is preparing for launch, leveraging a nuanced, evidence-based view of performance drivers – from prescriber adoption, to payer acceptance, to patient persistence – is essential to making the best decisions. Come join RWE experts from Trinity and Forian as they lead a lively discussion around the breadth and depth needed to construct an enlightening and actionable brand health assessment.
Sign up for the webinar here.